ZNTL ZENTALIS PHARMACEUTICALS
Price Chart
Executive Summary
Zentalis granted 191,000 non-qualified stock options to two newly hired employees as an inducement for employment, with a $3.98 exercise price and four-year vesting. This is a routine equity inducement grant with no material financial impact.
Actionable Insight
This is a routine inducement grant with negligible dilution. No trading signal — monitor upcoming clinical catalysts for azenosertib (WEE1 inhibitor) in ovarian cancer for material moves.
Key Facts
- 191,000 stock options granted to two new employees under the 2022 Inducement Plan
- Exercise price of $3.98 per share, equal to the closing price on the grant date
- Options vest over four years: 25% at first anniversary, then monthly over three years
- Grant is an inducement material to employment per Nasdaq Listing Rule 5635(c)(4)
Financial Impact
191,000 options at $3.98 strike; dilution is immaterial relative to ~50M shares outstanding (est. <0.4%)
Risk Factors
- No clinical or financial data disclosed; stock moves on pipeline events, not this grant
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3304753 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
1d ago
|
Institutional Cluster
| $3.51 awaiting T+1 | awaiting T+1 | — | $3.75 (+6.84%) |
|
Jun 1, 2026
11d ago
|
Press Release
| $3.95 $3.72 | ▼ −5.82% | ▼ −5.10% | $3.75 (−5.06%) |
|
May 21, 2026
22d ago
|
Press Release
| $4.06 $3.96 | ▼ −2.46% | ▼ −3.05% | $3.75 (−7.64%) |
|
May 21, 2026
22d ago
|
8-K
| $4.06 $3.96 | ▼ −2.46% | ▼ −3.05% | $3.75 (−7.64%) |
|
May 12, 2026
4w ago
|
8-K
| $4.28 $4.28 | · 0.00% | ▲ +0.00% | $3.75 (−12.38%) |
|
May 12, 2026
4w ago
|
Press Release
| $4.28 $4.28 | · 0.00% | ▲ +0.00% | $3.75 (−12.38%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $3.99 $3.84 | ▼ −3.76% | ▼ −4.78% | $3.75 (−6.02%) |
|
Apr 17, 2026
8w ago
|
Press Release
| $4.64 $4.03 | ▼ −13.15% | ▼ −12.95% | $3.75 (−19.18%) |
|
Apr 17, 2026
8w ago
|
8-K
| $4.64 $4.03 | ▼ −13.15% | ▼ −12.95% | $3.75 (−19.18%) |
|
Apr 9, 2026
9w ago
|
8-K
| $4.42 $6.61 | ▲ +49.55% | ▲ +49.61% | $3.75 (−15.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access